← Back to Search

Capsular Tension Ring

Capsular Tension Ring for Cataract (CTR Trial)

N/A
Recruiting
Research Sponsored by EyeKon Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial found that the CTR was safe and effective when used during cataract surgery to support the intraocular lens.

Eligible Conditions
  • Cataract Surgery

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Visual Acuity
Secondary study objectives
Adverse Events

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: DeviceExperimental Treatment1 Intervention
Polymethylmethacrylate Capsular Tension Ring introduced into the posterior chamber of the eye following cataract surgery before the implantation of an intraocular lens.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Capsular Tension Ring
2015
N/A
~120

Find a Location

Who is running the clinical trial?

EyeKon Medical, Inc.Lead Sponsor
1 Previous Clinical Trials
1 Trials studying Cataract Surgery
Mark RobinsonStudy DirectorSponsor/CEO

Media Library

Capsular Tension Ring (Capsular Tension Ring) Clinical Trial Eligibility Overview. Trial Name: NCT02332369 — N/A
Cataract Surgery Research Study Groups: Device
Cataract Surgery Clinical Trial 2023: Capsular Tension Ring Highlights & Side Effects. Trial Name: NCT02332369 — N/A
Capsular Tension Ring (Capsular Tension Ring) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02332369 — N/A
~6 spots leftby Dec 2025